Severe Mental Illness: Diagnosis, Pharmacological Management, and Monitoring

4


Event type International Expert Conference

EARLY BIRD OFFER OPEN!
Online webinar 09:30 - 12:30pm UK time
Can't make it, don't worry, book now as delegates have exclusive access to recordings for 90 days after the event, together with slides. You must book before the event starts, there are no tickets after the event starts.
Recordings from the session will be available to delegates from 5 working days after the event.

Marinos Kyriakopoulos

Psychosis and bipolar disorder in children and young people can present significant challenges for clinicians, from reaching an accurate diagnosis to making informed decisions about pharmacological management and monitoring their ongoing impact.

This ACAMH Expert Day brings together expert perspectives on the diagnosis and pharmacological management of these severe mental illnesses, with practical consideration of treatment monitoring, including the use of rating scales, physical health monitoring and the management of side effects. 

Register for the event & pricing

Sign up at this link or on the Book Now buttons, and complete the form that follows. You’ll then receive an email confirmation and a link to the webinar, plus we’ll send you a calendar reminder nearer the time.

Delegates will have exclusive access to recordings for 90 days after the event, together with slides. Plus you will get a personalised CPD/CME certificate via email. Recordings from the session will be available to delegates from 5 working days after the event.

  • ACAMH Members MUST login to book onto the webinar in order to access this webinar and get a CPD/CME certificate.
  • Non-members: this is a great time to join ACAMH, take a look at what we have to offer, and make the saving on these sessions.
Ticket Type Price
ACAMH paying Members (Online, Concession) EARLY BIRD £49 (until 30/10/26 then £69)(Join now and save)
ACAMH Learn Account Holders EARLY BIRD £69 (until 30/10/26 then £89)
Non Members EARLY BIRD £69 (until 30/10/26 then £89)
ACAMH Undergraduate/ Postgraduate Members £10
LMIC Members Free
Don’t forget as a charity any surplus made is reinvested back as we work to our vision of ‘Sharing best evidence, improving practice’, and our mission to ‘Improve the mental health and wellbeing of young people aged 0-25’.

Book Now

About the event

Three-hour ACAMH Expert Half-Day with Dr. Marinos Kyriakopoulos and Professor Dr. Aditya Sharma.  This online session will include dedicated presentations on psychosis and bipolar disorder in children and young people, followed by a joint session on treatment monitoring and a final discussion and Q&A.

Book Now

Who should attend

This event is primarily aimed at mental health practitioners working with children and young people, particularly clinical psychologists and child and adolescent psychiatrists (CAMHS). It is designed for professionals involved in the assessment and management of severe mental illness who want to deepen their knowledge of the diagnosis, pharmacological management and ongoing monitoring of psychosis and bipolar disorder in children and young people.

Book Now

About the Talks

This half-day event will present advanced clinical insights into the assessment and treatment of psychosis and bipolar disorder in children and adolescents. Early-onset severe mental illness present unique diagnostic challenges, often showing overlapping symptoms that complicate differential diagnosis from other neurodevelopmental and behavioural disorders. We will review the latest diagnostic criteria, assessment principles and management strategies focusing on current psychopharmacological guidelines, targeted psychotherapeutic interventions, and monitoring with the use of relevant rating scales. We will also discuss multidisciplinary care models and early intervention strategies aimed at improving long-term prognosis.

Dr. Marinos Kyriakopoulos – Psychosis in Children and Young People: Diagnosis and Pharmacological Management

Professor Dr. Aditya Sharma – Bipolar Disorder in Children and Young People: Diagnosis and Pharmacological Management

Dr. Marinos Kyriakopoulos and Professor Dr. Aditya Sharma – Monitoring Treatment in Severe Mental Illness: Rating Scales, Physical Health Monitoring and Managing Side Effects

Book Now

Programme Schedule
09:30 Welcome and Introduction
09:35 Professor Dr. Marinos Kyriakopoulos – Psychosis in Children and Young People: Diagnosis and Pharmacological Management
10:20 Reflections and refreshment
10:25 Professor Dr. Aditya Sharma – Bipolar Disorder in Children and Young People: Diagnosis and Pharmacological Management
11:10 Reflections and refreshment
11:25 Dr. Marinos Kyriakopoulos and Professor Dr. Aditya Sharma – Monitoring Treatment in Severe Mental Illness: Rating Scales, Physical Health Monitoring and Managing Side Effects
11:55 Dr. Marinos Kyriakopoulos and Professor Dr. Aditya Sharma – Discussion and Q&A
12:25  Closing remarks
12:30 Close

Book Now

About the Speakers

Marinos Kyriakopoulos

Dr. Marinos Kyriakopoulos PhD, FRCPsych is Assistant Professor in Child and Adolescent Psychiatry at the National and Kapodistrian University of Athens, Consultant Child and Adolescent Psychiatrist of the National and Specialist Autism and Intellectual Disability Intensive Intervention Team of South London and Maudsley NHS Foundation Trust and Visiting Senior Lecturer in Child and Adolescent Psychiatry at the Institute of Psychiatry, Psychology and Neuroscience, KCL. He has clinical and research interest in early-onset psychotic disorders, the interface between autism spectrum disorders and psychosis, developmental neuropsychiatry and psychopharmacology, and the stigma of mental health treatment in childhood.

aditya sharma

Professor Dr. Aditya Sharma is a Clinical Senior Lecturer and Hon Consultant in child and adolescent psychiatry at Translational and Clinical Research Institute, Newcastle University and Cumbria, Northumberland Tyne and Wear NHS Foundation Trust. Adi’s clinical academic interests include the epidemiology of, risk factors for the development of and management strategies to target the managment of Early Onset Mood Disorders to improve psychosocial outcomes and more recently global mental health. He leads on various psychopharmacology trials and also leads on various initiatives in digital mental health.

Book Now